Digital Edition: MedTech Strategist April 2025

article image
ARTICLE SUMMARY:

We debut a new investment column, Medtech Capital Matters; with Stryker spinal implants buy, the Viscogliosis expand their holistic approach to chronic back pain; FDA-approved AID systems trigger growth spurt in insulin pump market; tapping into the $41 billion women's health opportunity; overcoming drug delivery drawbacks; and a profile of surgeon-inventor Luis Savastano and two of his endovascular start-ups.

×



This article is restricted to subscribers only.

Sign in to continue reading.

Questions?

We're here to help! Please contact us at: